UK markets open in 7 hours 11 minutes
NIKKEI 225
38,179.46 -49.64 (-0.13%) HANG SENG
19,115.06 +151.36 (+0.80%) CRUDE OIL
79.14 +0.02 (+0.03%) GOLD FUTURES
2,343.40 +0.40 (+0.02%) DOW
39,431.51 -81.29 (-0.21%) Bitcoin GBP
50,101.02 +1,185.36 (+2.42%)
Celldex Therapeutics, Inc. (TCE2.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:12AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 2.44B |
| Enterprise value | 1.68B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 344.69 |
| Price/book (mrq) | 3.20 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.60 |
| 52-week change 3 | 20.38% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 47.80 |
| 52-week low 3 | 21.20 |
| 50-day moving average 3 | 38.52 |
| 200-day moving average 3 | 31.69 |
Share statistics
| Avg vol (3-month) 3 | 12 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 65.91M |
| Implied shares outstanding 6 | 66.62M |
| Float 8 | 62.27M |
| % held by insiders 1 | 0.34% |
| % held by institutions 1 | 99.39% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 11 Feb 2019 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -26,030.77% |
Management effectiveness
| Return on assets (ttm) | -15.73% |
| Return on equity (ttm) | -25.39% |
Income statement
| Revenue (ttm) | 6.07M |
| Revenue per share (ttm) | 0.12 |
| Quarterly revenue growth (yoy) | -83.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -147.12M |
| Net income avi to common (ttm) | -144.88M |
| Diluted EPS (ttm) | -2.65 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 823.85M |
| Total cash per share (mrq) | 12.5 |
| Total debt (mrq) | 2.11M |
| Total debt/equity (mrq) | 0.25% |
| Current ratio (mrq) | 31.77 |
| Book value per share (mrq) | 12.72 |
Cash flow statement
| Operating cash flow (ttm) | -119.36M |
| Levered free cash flow (ttm) | -54.98M |
© 2024 Yahoo. All rights reserved.